Lv1
10 积分 2024-05-03 加入
Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa
1个月前
已完结
Federal Oversight of Laboratory-Developed Tests
1个月前
已完结
Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study
3个月前
已完结
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
3个月前
已完结
Long-COVID treatments: why the world is still waiting
3个月前
已完结
Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant
3个月前
已完结
Mechanisms of long COVID and the path toward therapeutics
4个月前
已完结
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
4个月前
已完结
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study
5个月前
已完结
The current therapeutic cancer vaccines landscape in non‐small cell lung cancer
5个月前
已完结
皖公网安备34019202002308
